Page last updated: 2024-10-30

labetalol and Bleeding

labetalol has been researched along with Bleeding in 2 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Research Excerpts

ExcerptRelevanceReference
"In a model of uncontrolled hemorrhagic hypotension (UCHH) in rats, we examined whether blood loss or blood chemistry were affected by (1) deliberate, controlled hypotension induced with labetalol (L) or sodium nitroprusside (SNP) and (2) intravenous (iv) fluid therapy."7.70Labetalol-induced hypotension decreases blood loss during uncontrolled hemorrhage. ( Artru, AA; Geva, D; Gurevich, B; Gurman, G; Shapira, Y, 1998)
"In a model of uncontrolled hemorrhagic hypotension (UCHH) in rats, we examined whether blood loss or blood chemistry were affected by (1) deliberate, controlled hypotension induced with labetalol (L) or sodium nitroprusside (SNP) and (2) intravenous (iv) fluid therapy."3.70Labetalol-induced hypotension decreases blood loss during uncontrolled hemorrhage. ( Artru, AA; Geva, D; Gurevich, B; Gurman, G; Shapira, Y, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gurevich, B1
Artru, AA1
Geva, D1
Gurman, G1
Shapira, Y1
McNulty, S1
Sharifi-Azad, S1
Farole, A1

Other Studies

2 other studies available for labetalol and Bleeding

ArticleYear
Labetalol-induced hypotension decreases blood loss during uncontrolled hemorrhage.
    Resuscitation, 1998, Volume: 38, Issue:1

    Topics: Animals; Antihypertensive Agents; Combined Modality Therapy; Evaluation Studies as Topic; Fluid Ther

1998
Induced hypotension with labetalol for orthognathic surgery.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 1987, Volume: 45, Issue:4

    Topics: Hemoglobins; Hemorrhage; Humans; Hypotension, Controlled; Injections, Intravenous; Jaw Diseases; Lab

1987